menu search

Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney Conference

Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney Conference
LOS ALTOS, Calif., July 20, 2023 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that Shalabh Gupta, M.D., Chief Executive Officer will participate in a fireside chat at the H.C. Wainwright 2nd Annual Kidney Conference “Glomerular Disease: IgAN Is […] The post Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney Con... Read More
Posted: Jul 20 2023, 11:03
Author Name: forextv
Views: 080972

Search within

Pages Search Results: